据知情人士透露，白宫最早将于周五宣布与制药巨头诺华制药和罗氏（Roche）达成药品定价协议。此举将进一步缓解美国与瑞士之间因关税争端而产生的贸易紧张关系。其他药企也可能被纳入此次公告。今年夏天，特朗普曾致信17家制药公司，要求它们降低向美国政府医保项目收取的药价，同意通过一个“特朗普品牌”的直销平台销售药品，并将未来在美国的售价调整至与其他高收入国家相当的水平。作为交换，这些公司获得了数年暂缓征收关税和免受某些潜在监管措施的保护。近几个月来，辉瑞、阿斯利康等公司已与特朗普政府达成类似协议，在某些情况下同意降低药价以换取关税豁免。然而，其他多数药企至今尚未宣布达成协议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.